Centre for International Health

Studenter som drikker kaffe utenfor SV-fakultetet

CIH’s research, teaching and capacity building in global health will contribute to improved health in the poorer countries of the world. CIH will educate the best students in Global Health.

CIH is situated in Overlege Danielsens House, Årstadveien 21.

Travel safety info. (general) Travel Registry (only in Norwegian)

Global Health Norway Conference 2-3 April, 2019: Competence building for impact - time for revolution

10.4.2019 Common Deadline for RCN funding

CIH collaborates with partners at the Department of Global Public Health and Primary Care and the Faculty of Medicine as well as across Departments and Faculties at the University of Bergen (UiB), and at many other national and international institutions. CIH is responsible for Global Challenges, one of three of UiB's cross-Faculty strategic focus areas. 

CIH hosts the Secretariats for the Norwegian Global Health Forum and the Global Health Norway. It also hosts a Centre of Excellence, the Centre for Intervention Science in Maternal and Child Health (CISMAC).

PhD Candidates
Ingrid Nordeide Kuiper

Ingrid Nordeide Kuiper: Air Pollution – a Major Public Health Threat

PhD Candidate Ingrid Nordeide Kuiper examines the lung health effects of air pollution and greenness - over time and across generations.

Research coordinator Linn Knudsen in conversation with the expert panel

Explaining global health priorities

GHP kicking of Day Zero at the SDG 2019 conference with the "Global health priorities explained" seminar.

international study
Ugandan News

International study in the Ugandan News

The study involves researchers from Norway, England and Uganda. It will investigate how relatively simple measures relating to hand hygiene can help to prevent newborn infections in Uganda.

PhD Candidates
Chola Nakazwe

Chola Nakazwe: Assessing the changing HIV epidemiology in Zambia

The HIV epidemic is changing in Zambia. Nakazwe’s PhD research aims to examine some of the underlying socio-economic and contextual factors associated with this process.

PhD Candidates
Temsunaro Rongsen-Chandola administering an oral rotavirus vaccine in India

Temsunaro Rongsen-Chandola: Rotavirus Vaccines in India

Temsunaro Rongsen-Chandola’s research involved a randomised, double blind, placebo-controlled trial in India testing a live oral rotavirus vaccine in newborns (at 6, 10 and 14 weeks of age).